Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1991 2
1994 1
1995 1
1998 1
2002 2
2006 2
2007 1
2008 1
2011 2
2012 2
2013 1
2014 5
2015 4
2017 2
2018 1
2019 6
2020 1
2021 1
2022 8
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E. Jacobsen E. Am J Hematol. 2022 Dec;97(12):1638-1651. doi: 10.1002/ajh.26737. Epub 2022 Oct 18. Am J Hematol. 2022. PMID: 36255040 Free article.
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. ...Cytopenias are relatively common but constitutional symptoms of fever, night sweats, and weight loss are uncommon in …
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicu …
Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A, Jacobsen E. Freedman A, et al. Am J Hematol. 2020 Mar;95(3):316-327. doi: 10.1002/ajh.25696. Epub 2019 Dec 22. Am J Hematol. 2020. PMID: 31814159 Free article. Review.
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. ...Cytopenias are relatively common but constitutional symptoms of fever, night sweats, and weight loss are uncommon in …
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicu …
Follicular lymphoma: an update on diagnosis, prognosis, and management.
Mozas P, Sorigué M, López-Guillermo A. Mozas P, et al. Med Clin (Barc). 2021 Nov 12;157(9):440-448. doi: 10.1016/j.medcli.2021.03.041. Epub 2021 Jun 29. Med Clin (Barc). 2021. PMID: 34210513 Review. English, Spanish.
Follicular lymphoma, the most common indolent lymphoma, originates from germinal centre B-cells of the lymphoid follicle, and is characterized by t(14;18). ...Although overall survival for most patients is prolonged, relapses are very frequent, and early relapse and …
Follicular lymphoma, the most common indolent lymphoma, originates from germinal centre B-cells of the lymphoid follicle, and …
Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma.
Nastoupil LJ, Bartlett NL. Nastoupil LJ, et al. J Clin Oncol. 2023 Feb 1;41(4):903-913. doi: 10.1200/JCO.22.01848. Epub 2022 Dec 12. J Clin Oncol. 2023. PMID: 36508700 Review.
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group of morphologically, genetically, and clinically distinct diseases. ...We will review the practice-changing studies in frontline (POLARIX), ea …
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group o …
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
Casulo C, Larson MC, Lunde JJ, Habermann TM, Lossos IS, Wang Y, Nastoupil LJ, Strouse C, Chihara D, Martin P, Cohen JB, Kahl BS, Burack WR, Koff JL, Mun Y, Masaquel A, Wu M, Wei MC, Shewade A, Li J, Cerhan J, Flowers CR, Link BK, Maurer MJ. Casulo C, et al. Lancet Haematol. 2022 Apr;9(4):e289-e300. doi: 10.1016/S2352-3026(22)00033-3. Lancet Haematol. 2022. PMID: 35358443 Free PMC article.
BACKGROUND: Novel therapies for relapsed or refractory follicular lymphoma are commonly evaluated in single-arm studies without formal comparison with other treatments or historical controls. ...For this analysis, eligible patients were aged at least 18 years, had …
BACKGROUND: Novel therapies for relapsed or refractory follicular lymphoma are commonly evaluated in single-arm studies withou …
Marginal Zone Lymphoma: State-of-the-Art Treatment.
Sindel A, Al-Juhaishi T, Yazbeck V. Sindel A, et al. Curr Treat Options Oncol. 2019 Dec 5;20(12):90. doi: 10.1007/s11864-019-0687-5. Curr Treat Options Oncol. 2019. PMID: 31807935 Review.
Despite being the second most common indolent non-Hodgkin's lymphoma (iNHL), marginal zone lymphoma (MZL) remains largely understudied, and given its underlying disease heterogeneity, it is challenging to define a single treatment approach for these pa …
Despite being the second most common indolent non-Hodgkin's lymphoma (iNHL), marginal zone lymphoma (MZL) remain …
Follicular lymphoma: 2018 update on diagnosis and management.
Freedman A. Freedman A. Am J Hematol. 2018 Feb;93(2):296-305. doi: 10.1002/ajh.24937. Am J Hematol. 2018. PMID: 29314206 Free article. Review.
DISEASE OVERVIEW: Follicular lymphoma is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. ...Randomized studies have shown additional benefit for maintenance rituximab both following chemotherapy-rituximab and singl …
DISEASE OVERVIEW: Follicular lymphoma is generally an indolent B cell lymphoproliferative disorder of transformed follicular c …
Treatment of follicular lymphoma.
Izutsu K. Izutsu K. J Clin Exp Hematop. 2014;54(1):31-7. doi: 10.3960/jslrt.54.31. J Clin Exp Hematop. 2014. PMID: 24942944 Free article. Review.
Patients with FL who achieve remission eventually relapse and require salvage therapy. The salvage regimen should be chosen taking into account previous treatment and its response duration. Moreover, the presence of histological transformation should be assessed....
Patients with FL who achieve remission eventually relapse and require salvage therapy. The salvage regimen should be chosen taking in …
Follicular lymphoma: 2014 update on diagnosis and management.
Freedman A. Freedman A. Am J Hematol. 2014 Apr;89(4):429-36. doi: 10.1002/ajh.23674. Am J Hematol. 2014. PMID: 24687887 Free article. Review.
DISEASE OVERVIEW: Follicular lymphoma is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. ...Randomized studies have shown additional benefit for maintenance rituximab both following chemotherapy-rituximab and singl …
DISEASE OVERVIEW: Follicular lymphoma is generally an indolent B cell lymphoproliferative disorder of transformed follicular c …
Management of aggressive lymphoma after CAR T-cell therapy failure.
Nastoupil LJ, Kambhampati S. Nastoupil LJ, et al. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):364-369. doi: 10.1182/hematology.2023000437. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066908 Review.
Several recent advances have affected the treatment landscape of diffuse large B-cell lymphoma. Chimeric antigen receptor (CAR) T-cell therapy has transformed the management of chemorefractory disease. ...There is a growing population of patients previously t …
Several recent advances have affected the treatment landscape of diffuse large B-cell lymphoma. Chimeric antigen receptor (CAR) T-cel …
45 results